Contract Manufacturing

News

Manufacturing hangover drives Daiichi Sankyo into the red

Long-term third-party manufacturing contracts and a slower-than-expected rollout of its cancer ADCs have driven Daiichi Sankyo into a net loss.

Market Access

US-Chinese relations put the brakes on biotech cooperation

The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing.

Market Access

Collaboration is key to tackling geographical boundaries in ...

Unlike most biopharmaceuticals, it is often a struggle to manufacture cell and gene therapies (CGTs) in disparate geographies.

Oncology

CAR-TCR 2023 – Tim McGuire

As the cell therapy world has heated up, so too has the world of cell and gene therapy contract manufacturing.

Partner Content

Radiopharma CDMO SpectronRx Continues Growth

Partner Content

SpectronRx Receives U.S. Nuclear Regulatory Commission Mater...

Leading Radiopharma CDMO Opens Second Location

Manufacturing hangover drives Daiichi Sankyo into the red

US-Chinese relations put the brakes on biotech cooperation

Collaboration is key to tackling geographical boundaries in ...

CAR-TCR 2023 – Tim McGuire

SpectronRx Receives U.S. Nuclear Regulatory Commission Mater...

ASCO 2026: All about DNA damage response, with Luke Piggot

Discover a new era of healthcare panel engagement: Grounded ...

Contract Manufacturing

Editor's Picks